Eli Lilly is a leader in weight loss drugs, a market that may reach $95 billion by the end of the decade. Viking Therapeutics is heading toward the finish line with a drug that could compete with ...

Eli Lilly is a leader in weight loss drugs, a market that may reach $95 billion by the end of the decade. Viking Therapeutics is heading toward the finish line with a drug that could compete with ...

Eli Lilly (NYSE: LLY) and Viking Therapeutics (NASDAQ: VKTX) offer investors the chance to invest in one of today's highest-potential industries: weight loss drugs. The market for these products, ...

Isabel Wall, 2025’s Editor of the Year at The British Book Awards, has been promoted to the newly created role of executive publisher at Viking, Penguin General, effective immediately. In the new role ...

Viking Therapeutics, Inc.'s VK2735 oral trial met efficacy and safety endpoints, but high discontinuation rates and modest weight loss disappointed Wall Street, triggering a steep sell-off. Despite ...

Viking Holdings Ltd (NYSE:VIK) will release earnings results for the second quarter, before the opening bell on Tuesday, Aug. 19. Analysts expect the Pembroke, Bermuda-based company to report ...